½ÃÀ庸°í¼­
»óǰÄÚµå
1269686

¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : ¼ÒÀ纰(È÷¾Ë·ç·Ð»ê, ÇÏÀ̵å·Ï½Ã¾ÆÆÄŸÀÌÆ®Ä®½·, Æú¸®L¶ôÆ®»ê, PMMA(Æú¸®), Áö¹æÇÊ·¯, ±âŸ), Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2022-2029³â)

Global Dermal Fillers Market Size study & Forecast, by Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly ), Fat Fillers, Others) by Product, by Application, by End-User, and Regional Analysis, 2022-2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀåÀº 2021³â¿¡ ¾à 50¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í, ¿¹Ãø±â°£ 2022-2029³â¿¡´Â 7.4% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´õ¸» ÇÊ·¯´Â ÀϽÃÀûÀ¸·Î ÀÛÀº ÁÖ¸§À» ÁÙÀÌ°í ¾ó±¼ ÁÖ¸§À» ºÎµå·´°ÔÇϰí ÁÖ¸§À» ºÎµå·´°ÔÇÏ´Â µ¥ »ç¿ëµÇ´Â ÃÖ¼Òħ½ÀÀû ÀÎ ¹Ì¿ë¹ýÀÔ´Ï´Ù. À̰ÍÀº ÁÖ»ç °¡´ÉÇÑ Á© ¸ð¾çÀÇ ¹°Áú·Î ¾ó±¼ ÇǺο¡ Å« ºÎÇ®¾î ¿À¸£°í º¼·ýÀ» ºÎ¿©ÇÏ¿© ¸Å·ÂÀûÀÎ È¿°ú¸¦ ¸¸µå´Â µ¥ »ç¿ëµË´Ï´Ù. ´õ¸» ÇÊ·¯¿¡´Â Æú¸®¸ÞÆ¿¸ÞŸũ¸±·¹ÀÌÆ®, Æú¸®L ¶ôÆ®»ê, È÷¾Ë·ç·Ð»ê(HA)(PMMA)ÀÇ ¹Ì¼Ò±¸ µî ´Ù¾çÇÑ ¼ÒÀç°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ÇÇºÎ ÃæÀüÁ¦´Â ÈäÅÍ Á¦°Å, ÀÔ¼ú °­Á¶, ÁÖ¸§ °¨¼Ò, ¼Õ½ÇµÈ º¼·ý º¹±¸ µî ´Ù¾çÇÑ ¸ñÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ³²¼º¿¡¼­ ÇÊ·¯ ÁÖÀÔÀÇ º¸±Þ, ½ÅÈï±¹ ½ÃÀå¿¡¼­ ¾ó±¼ÀÇ ¹Ì¿ë¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶, °í·ÉÀÚ Àα¸ÀÇ ±ÞÁõ µîÀÌ, ¼¼°è¿¡¼­ ½ÃÀå ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ´Â ÁÖ¿ä ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ħ½À¼ºÀÌ ³·Àº ¹Ì¿ë ¼ºÇü ¼ö¼ú°ú ´õ¸» ÇÊ·¯ ½Ã¼úÀÇ ¼ö¿ä Áõ°¡´Â ¼¼°èÀûÀ¸·Î Å« ½ÃÀå ¼ºÀåÀ» °¡Á®¿Â ÁÖ¿ä ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ¼ºÇü¿Ü°úÇÐȸÀÇ Á¶»ç¿¡ µû¸£¸é. ¹Ì±¹¿¡¼­´Â 2020³â¿¡ ½Ç½ÃµÈ ¹Ì¿ë ¼ºÇü ¼ö¼úÀº 1,320¸¸ °Ç ÀÌ»óÀ̸ç, ±× Áß 340¸¸ °ÇÀÌ ¿¬Á¶Á÷ ÇÊ·¯¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼³µæ·ÂÀÖ´Â µ¥ÀÌÅÍ´Â ¹Ì¿ë ¼ºÇü ¼ö¼úÀÇ ¼ö¿ä°¡ ±Þ°ÝÈ÷ Áõ°¡Çϰí ÀÖÀ½À» ´õ¿í Áõ¸íÇÕ´Ï´Ù. ¶ÇÇÑ ±¹Á¦¹Ì¿ëÁ¤Çü¿Ü°úÇÐȸ(ISAPS)¿¡ µû¸£¸é 2018³â¿¡ ºñÇØ 2019³â¿¡ ¼¼°è¿¡¼­ ¾à 4,315,859°ÇÀÇ È÷¾Ë·ç·Ð»ê ÇÊ·¯ Ä¡·á°¡ ÀÌ·ç¾îÁø °ÍÀ¸·Î Æò°¡µÇ°í ÀÖÀ¸¸ç, ÀÌ´Â 15.7%ÀÇ »ó½ÂÀ» ³ªÅ¸³Â´Ù. Çß½À´Ï´Ù. ÀÌ·± ½ÄÀ¸·Î ¹ÌÀû ¼ö¼úÀÇ ¾çÀÌ Áõ°¡ÇÏ´Â °ÍÀº ¿¹Ãø±â°£ µ¿¾È ½ÃÀå È®´ë¸¦ ´õ¿í Áö¿øÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °Ô´Ù°¡, »õ·Î¿î ÇÊ·¯ÀÇ °³¹ßÀ» À§ÇÑ R&D ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡¿Í ÀÇ·á ¹× ¹Ì¿ë Á¦Ç°ÀÇ ±â¼úÀû Áøº¸ÀÇ Áõ°¡´Â ¿¹»óµÇ´Â ¼ö³â°£ÀÇ ½ÃÀå ¼ºÀåÀ» À§ÇÑ ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ´õ¸» ÇÊ·¯ ½Ã¼ú·Î ÀÎÇÑ »ó´ëÀûÀÎ ºÎÀÛ¿ë°ú Á¦Ç°°ú °ü·ÃµÈ ³ôÀº ºñ¿ëÀº 2022³âºÎÅÍ 2029³â±îÁöÀÇ ¿¹Ãø±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù.

´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì ¹× ±âŸ ¼¼°è Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ½ÅÁ¦Ç° Ãâ½ÃÀÇ Áõ°¡¿Í ÇÔ²² È÷¾Ë·ç·Ð»ê ½Ã¼úÀÇ ¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ¼öÀ͸鿡¼­ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÇÑÆí ¾Æ½Ã¾ÆÅÂÆò¾çÁö¿ªÀº ¿ÜÇü¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö¸é¼­ °í·ÉÈ­ »çȸÀÇ ÁøÀü, °¡Ã³ºÐ¼Òµæ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ¿¹Ãø±â°£ Áß °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇÏ°í ¾ÕÀ¸·Î ¼ö³â°£ÀÇ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ¼¼°è¡¤ºÎ¹®º° ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • ´õ¸» ÇÊ·¯ ½ÃÀå, Áö¿ªº°, 2019-2029³â
    • ´õ¸» ÇÊ·¯ ½ÃÀå, ¼ÒÀ纰, 2019-2029³â
    • ´õ¸» ÇÊ·¯ ½ÃÀå, Á¦Ç°º°, 2019-2029³â
    • ´õ¸» ÇÊ·¯ ½ÃÀå, ¿ëµµº°, 2019-2029³â
    • ´õ¸» ÇÊ·¯ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2029³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ °¡Á¤

Á¦2Àå ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • Á¶»ç ´ë»ó ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
  • º» Á¶»çÀÇ ´ë»óÀÌ µÈ ÇØ
  • ȯÀ² º¯È¯À²

Á¦3Àå ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå ¿ªÇÐ

  • ´õ¸» ÇÊ·¯ ½ÃÀåÀÇ ¿µÇ⠺м®(2019-2029³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ÃÖ¼Òħ½À ¹Ì¿ë ½Ã¼ú°ú ´õ¸» ÇÊ·¯ ½Ã¼ú ¼ö¿ä Áõ°¡
      • ¼±Áø±¹¿¡¼­ÀÇ ÆäÀÌ¼È ¿¡½ºÅׯ½¿¡ °üÇÑ ÀǽÄÀÇ °íÁ¶
    • ½ÃÀåÀÇ °úÁ¦
      • ´õ¸» ÇÊ·¯ ½Ã¼úÀÇ »ó´ëÀûÀÎ ºÎÀÛ¿ë¿¡ ´ëÇØ
      • Á¦Ç°°ú °ü·ÃµÈ ³ôÀº ºñ¿ë
    • ½ÃÀå ±âȸ
      • ½Å±Ô ÇÊ·¯ °³¹ßÀ» ÇâÇÑ ¿¬±¸ °³¹ß¿¡ÀÇ ´ëó°¡ Ȱ¹ßÈ­
      • ÀÇ·á¿ë ¹Ì¿ë Á¦Ç°ÀÇ ±â¼ú Áøº¸ÀÇ Áõ°¡

Á¦4Àå ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ Àû´ë °ü°è
  • Porter's 5 Force ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù(2019-2029³â)
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ¾÷°è °ü°èÀÚ Àü¸Á
  • ¾Ö³Î¸®½ºÆ®ÀÇ ±Ç°í¿Í °á·Ð

Á¦5Àå À§Çè Æò°¡: COVID-19ÀÇ ¿µÇâ

  • COVID-19°¡ ¾÷°è¿¡ ¹ÌÄ¡´Â ÀüüÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ Æò°¡
  • COVID-19 ÀÌÀü°ú COVID-19 ÀÌÈÄÀÇ ½ÃÀå ½Ã³ª¸®¿À

Á¦6Àå ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : ¼ÒÀ纰

  • ½ÃÀå ÇöȲ
  • ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : ¼ÒÀ纰, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : ¼ÒÀ纰 ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • ´õ¸» ÇÊ·¯ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • È÷¾Ë·ç·Ð»ê
    • Ä®½· ÇÏÀ̵å·Ï½Ç ¾ÆÆÄŸÀÌÆ®
    • Æú¸® L ¶ôÆ®»ê
    • PMMA(Poly(Methyl Methacrylate))
    • ÆÖ ÇÊ·¯
    • ±âŸ

Á¦7Àå ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • ´õ¸» ÇÊ·¯ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • »ýºÐÇØ¼º
    • ºñ»ýºÐÇØ¼º

Á¦8Àå ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : ¿ëµµº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • ´õ¸» ÇÊ·¯ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • »óóÀÇ Ä¡·á
    • ÁÖ¸§ ±³Á¤ Ä¡·á
    • ¸³ °­È­
    • º¼·ý º¹¿ø
    • ±âŸ

Á¦9Àå ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ÇöȲ
  • ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°), ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • ´õ¸» ÇÊ·¯ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Àü¹®ÀÇ¡¤ÇǺΰú Ŭ¸®´Ð
    • º´¿ø°ú Ŭ¸®´Ð
    • ±âŸ

Á¦10Àå ´õ¸» ÇÊ·¯ ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ´õ¸» ÇÊ·¯ ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • ¼ÒÀ纰 ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • ij³ª´Ù
  • À¯·´ ´õ¸» ÇÊ·¯ ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ¼¼°èÀÇ ±âŸ Áö¿ª

Á¦11Àå °æÀï Á¤º¸

  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Revance Therapeutics, Inc.(US)
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¸¸)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Merz Pharma(Germany)
    • Galderma(Switzerland)
    • Sinclair Pharma(UK)
    • BIOPLUS CO., LTD.(South Korea)
    • Bioxis pharmaceuticals(France)
    • SCULPT Luxury Dermal Fillers LTD(Czech Republic)
    • DR. Korman Laboratories Ltd.(Israel)
    • Prollenium Medical Technologies(Canada)
    • Suneva Medical(US)

Á¦12Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»çÀÇ Æ¯Â¡
  • Á¶»çÀÇ °¡Á¤
ksm 23.05.24

Global Dermal Fillers Market is valued at approximately USD 5.05 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Dermal fillers are a minimally invasive aesthetic procedure used to temporarily reduce fine lines, soften creases on the face, and smooth out wrinkles. It is an injectable gel-like substance that is used to generate an attractive effect by giving the skin on the face greater fullness and volume. Dermal fillers contain a variety of materials, including microspheres of polymethyl methacrylate, poly-L-lactic acid, and hyaluronic acid (HA) (PMMA). Dermal fillers can be used for a variety of purposes, such as scar removal, lip enhancement, wrinkle reduction, and the restoration of lost volume. The increasing adoption of injectable fillers among the male population, rising awareness regarding facial aesthetics in developed nations, and the surging number of elderly populations are the primary factors that are bolstering the market demand around the world.

In addition, the increase in demand for minimally invasive cosmetic procedures and dermal filler procedures are the key factors that are attributing to the market growth at a substantial rate globally. According to the American Society of Plastic Surgeons study. In the United States, there were over 13.2 million cosmetic procedures performed in 2020, of which 3.4 million used soft tissue fillers. Such compelling data further demonstrates the sharp rise in demand for cosmetic operations. Also, according to the International Society of Aesthetic Plastic Surgery (ISAPS) it was assessed that around 4,315,859 hyaluronic acid filler treatments were carried out globally in 2019 in comparison to 2018, this marked a rise of 15.7%. Thus, the rise in the volume of aesthetic operations is anticipated to further support market expansion throughout the projected period. Furthermore, the increasing R&D initiatives for the development of new fillers, as well as rising technological advancement in medical aesthetic products are creating various lucrative opportunities for market growth over the anticipated years. However, relative side effects with the dermal filler procedure and high costs associated with products are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Dermal Fillers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing number of hyaluronic acid procedures, along with the rising regulatory approvals and new product launches. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing consciousness of individuals regarding their physical appearance, escalating aging population, as well as the increasing disposable income in the regional market.

Major market players included in this report are:

  • Revance Therapeutics, Inc. (U.S.)
  • Merz Pharma (Germany)
  • Galderma (Switzerland)
  • Sinclair Pharma (U.K.)
  • BIOPLUS CO., LTD. (South Korea)
  • Bioxis pharmaceuticals (France)
  • SCULPT Luxury Dermal Fillers LTD (Czech Republic)
  • DR. Korman Laboratories Ltd. (Israel)
  • Prollenium Medical Technologies (Canada)
  • Suneva Medical (U.S.)

Recent Developments in the Market:

  • In February 2021, CollPlant and Allergan Aesthetica jointly announced a development and global commercial partnership to create and market dermal and soft tissue fillers using CollPlant's plant-derived recombinant human collagen (rhCollagen) and Allergan's patented technology.

Global Dermal Fillers Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Material, Product, Application, End-User, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Material:

  • Hyaluronic Acid
  • Calcium Hydroxylapatite
  • Poly-L-lactic Acid
  • PMMA (Poly (Methyl Methacrylate))
  • Fat Fillers
  • Others

By Product:

  • Biodegradable
  • Non-Biodegradable

By Application:

  • Scar Treatment
  • Wrinkle Correction Treatment
  • Lip Enhancement
  • Restoration of Volume/Fullness
  • Others

By End-User:

  • Specialty & Dermatology Clinics
  • Hospitals & Clinics
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Dermal Fillers Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Dermal Fillers Market, by Material, 2019-2029 (USD Billion)
    • 1.2.3. Dermal Fillers Market, by Product, 2019-2029 (USD Billion)
    • 1.2.4. Dermal Fillers Market, by Application, 2019-2029 (USD Billion)
    • 1.2.5. Dermal Fillers Market, by End-User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Dermal Fillers Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Dermal Fillers Market Dynamics

  • 3.1. Dermal Fillers Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing demand for minimally invasive cosmetic procedures and dermal filler procedures
      • 3.1.1.2. Rising awareness regarding facial aesthetics in developed nations
    • 3.1.2. Market Challenges
      • 3.1.2.1. Relative side effects with the dermal filler procedure
      • 3.1.2.2. High costs associated with products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing R&D initiatives for the development of new fillers
      • 3.1.3.2. Rising technological advancement in medical aesthetic products

Chapter 4. Global Dermal Fillers Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Dermal Fillers Market, by Material

  • 6.1. Market Snapshot
  • 6.2. Global Dermal Fillers Market by Material, Performance - Potential Analysis
  • 6.3. Global Dermal Fillers Market Estimates & Forecasts by Material 2019-2029 (USD Billion)
  • 6.4. Dermal Fillers Market, Sub Segment Analysis
    • 6.4.1. Hyaluronic Acid
    • 6.4.2. Calcium Hydroxylapatite
    • 6.4.3. Poly-L-lactic Acid
    • 6.4.4. PMMA (Poly (Methyl Methacrylate))
    • 6.4.5. Fat Fillers
    • 6.4.6. Others

Chapter 7. Global Dermal Fillers Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Dermal Fillers Market by Product, Performance - Potential Analysis
  • 7.3. Global Dermal Fillers Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 7.4. Dermal Fillers Market, Sub Segment Analysis
    • 7.4.1. Biodegradable
    • 7.4.2. Non-Biodegradable

Chapter 8. Global Dermal Fillers Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Dermal Fillers Market by Application, Performance - Potential Analysis
  • 8.3. Global Dermal Fillers Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 8.4. Dermal Fillers Market, Sub Segment Analysis
    • 8.4.1. Scar Treatment
    • 8.4.2. Wrinkle Correction Treatment
    • 8.4.3. Lip Enhancement
    • 8.4.4. Restoration of Volume/Fullness
    • 8.4.5. Others

Chapter 9. Global Dermal Fillers Market, by End-User

  • 9.1. Market Snapshot
  • 9.2. Global Dermal Fillers Market by End-User, Performance - Potential Analysis
  • 9.3. Global Dermal Fillers Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
  • 9.4. Dermal Fillers Market, Sub Segment Analysis
    • 9.4.1. Specialty & Dermatology Clinics
    • 9.4.2. Hospitals & Clinics
    • 9.4.3. Others

Chapter 10. Global Dermal Fillers Market, Regional Analysis

  • 10.1. Dermal Fillers Market, Regional Market Snapshot
  • 10.2. North America Dermal Fillers Market
    • 10.2.1. U.S. Dermal Fillers Market
      • 10.2.1.1. Material breakdown estimates & forecasts, 2019-2029
      • 10.2.1.2. Product breakdown estimates & forecasts, 2019-2029
      • 10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
      • 10.2.1.4. End-User breakdown estimates & forecasts, 2019-2029
    • 10.2.2. Canada Dermal Fillers Market
  • 10.3. Europe Dermal Fillers Market Snapshot
    • 10.3.1. U.K. Dermal Fillers Market
    • 10.3.2. Germany Dermal Fillers Market
    • 10.3.3. France Dermal Fillers Market
    • 10.3.4. Spain Dermal Fillers Market
    • 10.3.5. Italy Dermal Fillers Market
    • 10.3.6. Rest of Europe Dermal Fillers Market
  • 10.4. Asia-Pacific Dermal Fillers Market Snapshot
    • 10.4.1. China Dermal Fillers Market
    • 10.4.2. India Dermal Fillers Market
    • 10.4.3. Japan Dermal Fillers Market
    • 10.4.4. Australia Dermal Fillers Market
    • 10.4.5. South Korea Dermal Fillers Market
    • 10.4.6. Rest of Asia Pacific Dermal Fillers Market
  • 10.5. Latin America Dermal Fillers Market Snapshot
    • 10.5.1. Brazil Dermal Fillers Market
    • 10.5.2. Mexico Dermal Fillers Market
    • 10.5.3. Rest of Latin America Dermal Fillers Market
  • 10.6. Rest of The World Dermal Fillers Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Revance Therapeutics, Inc. (U.S.)
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Merz Pharma (Germany)
    • 11.2.3. Galderma (Switzerland)
    • 11.2.4. Sinclair Pharma (U.K.)
    • 11.2.5. BIOPLUS CO., LTD. (South Korea)
    • 11.2.6. Bioxis pharmaceuticals (France)
    • 11.2.7. SCULPT Luxury Dermal Fillers LTD (Czech Republic)
    • 11.2.8. DR. Korman Laboratories Ltd. (Israel)
    • 11.2.9. Prollenium Medical Technologies (Canada)
    • 11.2.10. Suneva Medical (U.S.)

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦